UK markets closed

Teladoc Health, Inc. (0LDR.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
13.35-0.41 (-2.98%)
At close: 04:46PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 3-39.83%
S&P500 52-week change 322.64%
52-week high 330.38
52-week low 313.22
50-day moving average 318.78
200-day moving average 320.80

Share statistics

Avg vol (3-month) 319.44k
Avg vol (10-day) 318.28k
Shares outstanding 570.11M
Implied shares outstanding 6N/A
Float 8165.55M
% held by insiders 10.77%
% held by institutions 171.26%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -8.47%
Operating margin (ttm)-4.53%

Management effectiveness

Return on assets (ttm)-3.01%
Return on equity (ttm)-9.51%

Income statement

Revenue (ttm)2.6B
Revenue per share (ttm)15.81
Quarterly revenue growth (yoy)3.60%
Gross profit (ttm)N/A
EBITDA 46.22M
Net income avi to common (ttm)-220.37M
Diluted EPS (ttm)-43.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.12B
Total cash per share (mrq)6.73
Total debt (mrq)1.6B
Total debt/equity (mrq)68.62%
Current ratio (mrq)3.54
Book value per share (mrq)13.96

Cash flow statement

Operating cash flow (ttm)350.02M
Levered free cash flow (ttm)306M